Inovio Pharmaceuticals Inc (NASDAQ:INO)

8.83
Delayed Data
As of May 22
 +0.57 / +6.90%
Today’s Change
6.33
Today|||52-Week Range
14.20
-3.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues3.2M1.2M2.5M5.2M
 
 
 
 
 
Depreciation And Amortization366.3K419.3K428.4K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses13.6M9.8M13.0M13.5M
 
 
 
 
 
Research And Development9.6M7.0M9.2M9.4M
 
 
 
 
 
Total Operating Expenses14.0M10.2M13.5M13.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M-8.9M-11.0M-8.4M
 
 
 
 
 
Extraordinary Credit824.4K--3.5M--
 
 
 
Extraordinary Charge0.00-114.0K---1.2K
 
 
 
Pre-Tax Equity Earnings-1.5M1.2M---2.4M
 
 
 
 
Other Expenses556.4K610.9K113.2K138.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.7M-7.2M-7.4M-10.6M
 
 
 
 
 
Minority Interest-6.4K-1.5K-1.1K-1.1K
 
 
 
 
 
Net Income-10.7M-7.2M-7.4M-10.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.2M60.4M60.6M60.7M
 
 
 
 
 
Shares To Calculate EPS Diluted60.2M60.6M60.8M60.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.19-$0.12-$0.12-$0.18
 
 
 
 
 
EPS Diluted-$0.18-$0.12-$0.12-$0.18
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account